Bexsero यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

bexsero

gsk vaccines s.r.l. - zunanjo membrano semenskih mešičkov iz neisseria meningitidis skupina b (sev nz 98/254), rekombinantne neisseria meningitidis skupina b fhbp fuzijski protein, rekombinantne neisseria meningitidis skupina b nada beljakovin, rekombinantne neisseria meningitidis skupina b nhba fuzijski protein - meningitis, meningokokni - meningococcal cepiva - aktivna imunizacija proti invazivni bolezni, ki jo povzročajo sevi neisseria meningitidis serogroup-b.

Iclusig यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

iclusig

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. glej poglavja 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Vankomicin Apta 1000 mg prašek za koncentrat za raztopino za infundiranje स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

vankomicin apta 1000 mg prašek za koncentrat za raztopino za infundiranje

apta medica internacional d.o.o. - vankomicin - prašek za koncentrat za raztopino za infundiranje - vankomicin 1000 mg / 1 viala - vankomicin